being and becoming in the world
The British Association for Psychopharmacology [BAP] provides this policy on relations with industry and other organisations. BAP confirms that this policy was agreed by BAP Council in July 2019 and … Continue reading BAP relationship with industry
At the forthcoming 2023 Summer Meeting of the British Association for Psychopharmacology [BAP] one of the ‘workshops’ for trainee doctors is titled ‘Public engagement – tips for best practice‘. Former … Continue reading Paid opinion leaders on public engagement
For UK psychiatrists the British Association for Psychopharmacology [BAP] is considered the premier educational resource. At the forthcoming 2023 Summer Meeting there are a number of ‘Satellite Symposia” sponsored by … Continue reading Yet more “education” funded by Industry
In October 2019, Professor Wendy Burn, President of the Royal College of Psychiatrists [2017-2020] openly stated: “Despite what some people think, most clinicians in the UK are not influenced by … Continue reading Is there evidence to support this statement?
Over the last decade I have looked at the governance of the Psychopharmacology Committee of the Royal College of Psychiatrists. My hope was to find improvement in relation to transparency. … Continue reading The Psychopharmacology Committee [2023]
Published in the current BMJ is this ‘Feature Essay’: Why doctors have a moral imperative to prescribe and support medical cannabis: The BMJ have published online several rapid responses to this … Continue reading ‘Entrenched resistance in the medical profession’
The following original research, which maps conflicts of interest, has been published in the current BMJ. It reveals that industry is FLOURISHING in the ‘healthcare ecosystem’ and concludes that: “Policies … Continue reading Mapping conflict of interests
Professor Wendy Burn, President of the Royal College of Psychiatrists [24 December 2019]: “The influence of pharma on most psychiatrists in the UK is negligible.” Dr Margaret McCartney has said, … Continue reading “The influence of pharma on most psychiatrists in the UK is negligible”